Announced Tue, 22 Apr · 15:38 IST

Compliance certificate under Reg 74(5) of SEBI (DP) Regulations, for quarter ended 31.03.2025.

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

ANG Lifesciences India Ltd has submitted a compliance certificate to BSE under SEBI's Depositories and Participants Regulations, 2018 for the quarter ended 31 March 2025. The certificate, issued by the company's Registrar and Share Transfer Agent (Bigshare Services Private Limited), confirms that all share certificates received from depository participants for dematerialization during the quarter were properly processed. It also confirms that dematerialized securities were listed on the stock exchange and that physical certificates were cancelled and substituted with the depository's name in the register of members within the required 15-day timeline. This is a routine regulatory filing with no new business or financial information disclosed.

Likely market impact

No impact on shareholders or stock price — this is a standard procedural compliance submission required quarterly and carries no material information.